Advertisement
News
Advertisement

Insulet drums up $85M from Cannacord Genuity

Mon, 01/14/2013 - 3:02pm
Mass Device

Insulet raises $85 million in a private placement with Cannaccord Genuity.

insulet logo

Insulet (NSDQ:PODD) inked a private placement deal with Canaccord Genuity for $85 million worth of its common stock.

The Bedford, Mass.-based insulin management company said it plans to use the fund for marketing its OmniPod insulin pump and product development,
the company said.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading